DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more
DreamCIS Inc (223250) - Total Liabilities
Latest total liabilities as of September 2025: ₩60.03 Billion KRW
Based on the latest financial reports, DreamCIS Inc (223250) has total liabilities worth ₩60.03 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DreamCIS Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how DreamCIS Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
DreamCIS Inc Competitors by Total Liabilities
The table below lists competitors of DreamCIS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Energy International Holding Co. Ltd
PINK:PVLTF
|
USA | $80.17 Billion |
|
IKIO Lighting Limited
NSE:IKIO
|
India | ₹1.49 Billion |
|
SNU Precision Co. Ltd
KQ:080000
|
Korea | ₩35.42 Billion |
|
Tambun Indah Land Bhd
KLSE:5191
|
Malaysia | RM100.84 Million |
|
Shree Rama Multi-Tech Limited
NSE:SHREERAMA
|
India | ₹457.44 Million |
|
DevvStream Holdings Inc.
OTCQB:DSTRF
|
USA | $5.39 Million |
|
CammSys Corp
KQ:050110
|
Korea | ₩151.08 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down DreamCIS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DreamCIS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DreamCIS Inc (2017–2024)
The table below shows the annual total liabilities of DreamCIS Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩50.58 Billion | +59.57% |
| 2023-12-31 | ₩31.70 Billion | +9.26% |
| 2022-12-31 | ₩29.01 Billion | +54.92% |
| 2021-12-31 | ₩18.73 Billion | +54.34% |
| 2020-12-31 | ₩12.13 Billion | -14.99% |
| 2019-12-31 | ₩14.27 Billion | +28.92% |
| 2018-12-31 | ₩11.07 Billion | +3.25% |
| 2017-12-31 | ₩10.72 Billion | -- |